Page 527 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 32 Acquired Disorders of Red Cell, White Cell, and Platelet Production 444.e3

103. Pasha SF, Pruthi RK: Procainamide-induced pure red cell aplasia. Int J 129. Hashimoto H, Maruyama H, Fujimoto K, et al: Hematologic findings
Cardiol 110:125, 2006. associated with thrombocytopenia during the acute phase of exanthem
104. Agudelo CA, Wise CM, Lyles MF: Pure red cell aplasia in procainamide subitum confirmed by primary human herpesvirus-6 infection. J Pediatr
induced systemic lupus erythematosus. Report and review of the litera- Hematol Oncol 24:211, 2002.
ture. J Rheumatol 15:1431, 1988. 130. Takikawa T, Hayashibara H, Harada Y, et al: Liver dysfunction,
105. Giannone L, Kugler JW, Krantz SB: Pure red cell aplasia associated anaemia, and granulocytopenia after exanthema subitum. Lancet
with administration of sustained-release procainamide. Arch Intern Med 340:1288, 1992.
147:1179, 1987. 131. Hillenbrand FK: The blood picture in rubella; its place in diagnosis.
106. MacDougall LG: Pure red cell aplasia associated with sodium valproate Lancet 271:66, 1956.
therapy. JAMA 247:53, 1982. 132. Lewis DE, Gilbert BE, Knight V: Influenza virus infection induces
107. Mariette X, Mitjavila MT, Moulinie JP, et al: Rifampicin-induced pure functional alterations in peripheral blood lymphocytes. J Immunol
red cell aplasia. Am J Med 87:459, 1989. 137:3777, 1986.
108. Anttila PM, Valimaki M, Pentikainen PJ: Pure-red-cell aplasia associ- 133. Amarapurkar DN, Amarapurkar AD: Extrahepatic manifestations of
ated with sulphasalazine but not 5-aminosalicylic acid. Lancet 2:1006, viral hepatitis. Ann Hepatol 1:192, 2002.
1985. 134. Iwamoto J, Hakozaki Y, Sakuta H, et al: A case of agranulocytosis
109. Dunn AM, Kerr GD: Pure red cell aplasia associated with sulphasala- associated with severe acute hepatitis B. Hepatol Res 21:181, 2001.
zine. Lancet 2:1288, 1981. 135. Ivarsson SA, Ljung R: Neutropenia and congenital cytomegalovirus
110. Strauss AM: Erythrocyte hypoplasia following sulfathiazole. Am J Clin infection. Pediatr Infect Dis J 7:436, 1988.
Path 13:249, 1943. 136. Avanzini A, Colombo T, Santucci S: Neutropenia in a cytomegalovirus
111. Sanz MA, Martinez JA, Gomis F, et al: Sulindac-induced bone marrow (CMV) infected VVLBW infant. Acta Paediatr Scand 80:738, 1991.
toxicity. Lancet 2:802, 1980. 137. Almeida-Porada GD, Ascensao JL: Cytomegalovirus as a cause of
112. Misra S, Moore TB, Ament ME, et al: Red cell aplasia in children on pancytopenia. Leuk Lymphoma 21:217, 1996.
tacrolimus after liver transplantation. Transplantation 65:575, 1998. 138. Savard M, Gosselin J: Epstein-Barr virus immunosuppression of innate
113. De Renzo A, Formisano S, Rotoli B: Bone marrow aplasia and thiam- immunity mediated by phagocytes. Virus Res 119:134, 2006.
phenicol. Haematologica 66:98, 1981. 139. Imashuku S, Tabata Y, Teramura T, et al: Treatment strategies for
114. Yamamoto N, Shiraki K, Saitou Y, et al: Ticlopidine induced acute Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
cholestatic hepatitis complicated with pure red cell aplasia. J Clin (EBV-HLH). Leuk Lymphoma 39:37, 2000.
Gastroenterol 38:84, 2004. 140. Corcione A, Roncella S, Cutrona G, et al: Transforming growth factor
115. Ertorer ME, Gokcel A, Savas L, et al: Ticlopidine-induced marrow beta-1 (TGF-beta 1) released by an Epstein-Barr virus (EBV) positive
aplasia treated with cyclosporine. Clin Appl Thromb Hemost 8:183, spontaneous lymphoblastoid cell line from a patient with Kostmann’s
2002. congenital neutropenia inhibits the growth of normal committed
116. Watts RG, Emanuel PD, Zuckerman KS, et al: Valproic acid-induced haemopoietic progenitors in vitro. Br J Haematol 85:684, 1993.
cytopenias: Evidence for a dose-related suppression of hematopoiesis. J 141. Zon LI, Groopman JE: Hematologic manifestations of the human
Pediatr 117:495, 1990. immune deficiency virus (HIV). Semin Hematol 25:208, 1988.
117. Weinkove R, Rangarajan S, van der Walt J, et al: Zidovudine-induced 142. Mulder AB, de Wolf JT, Smit JW, et al: Correction of neutropenia by
pure red cell aplasia presenting after 4 years of therapy. AIDS 19:2046, GM-CSF in patients with a large granular lymphocyte proliferation.
2005. Ann Hematol 65:91, 1992.
118. Go RS, Li CY, Tefferi A, et al: Acquired pure red cell aplasia associated 143. McClain K, Estrov Z, Chen H, et al: Chronic neutropenia of child-
with lymphoproliferative disease of granular T lymphocytes. Blood hood: Frequent association with parvovirus infection and correlations
98:483, 2001. with bone marrow culture studies. Br J Haematol 85:57, 1993.
119. Chikkappa G, Pasquale D, Phillips PG, et al: Cyclosporin-A for the 144. Koch WC, Massey G, Russell CE, et al: Manifestations and treatment
treatment of pure red cell aplasia in a patient with chronic lymphocytic of human parvovirus B19 infection in immunocompromised patients.
leukemia. Am J Hematol 26:179, 1987. J Pediatr 116:355, 1990.
120. Means RT, Jr, Dessypris EN, Krantz SB: Treatment of refractory pure 145. Doran HM, Teall AJ: Neutropenia accompanying erythroid aplasia in
red cell aplasia with cyclosporine A: Disappearance of IgG inhibitor human parvovirus infection. Br J Haematol 69:287, 1988.
associated with clinical response. Br J Haematol 78:114, 1991. 146. Bozoky G, Ruby E, Goher I, et al: Hematologic abnormalities in
121. Au WY, Lam CC, Chim CS, et al: Alemtuzumab induced complete pulmonary tuberculosis]. Orv Hetil 138:1053, 1997.
remission of therapy-resistant pure red cell aplasia. Leuk Res 29:1213, 147. Maartens G, Willcox PA, Benatar SR: Miliary tuberculosis: Rapid
2005. diagnosis, hematologic abnormalities, and outcome in 109 treated
122. Clark DA, Dessypris EN, Krantz SB: Studies on pure red cell aplasia. adults. Am J Med 89:291, 1990.
XI. Results of immunosuppressive treatment of 37 patients. Blood 148. al Eissa Y, al Nasser M: Haematological manifestations of childhood
63:277, 1984. brucellosis. Infection 21:23, 1993.
123. Zecca M, De Stefano P, Nobili B, et al: Anti-CD20 monoclonal 149. Crosby E, Llosa L, Miro QM, et al: Hematologic changes in brucellosis.
antibody for the treatment of severe, immune-mediated, pure red cell J Infect Dis 150:419, 1984.
aplasia and hemolytic anemia. Blood 97:3995, 2001. 150. Galanakis E, Bourantas KL, Leveidiotou S, et al: Childhood brucellosis
124. Lacy MQ, Kurtin PJ, Tefferi A: Pure red cell aplasia: Association in north-western Greece: A retrospective analysis. Eur J Pediatr 155:1,
with large granular lymphocyte leukemia and the prognostic value of 1996.
cytogenetic abnormalities. Blood 87:3000, 1996. 151. Syrjala H: Peripheral blood leukocyte counts, erythrocyte sedimenta-
125. Charles RJ, Sabo KM, Kidd PG, et al: The pathophysiology of pure tion rate and C-reactive protein in tularemia caused by the type B strain
red cell aplasia: Implications for therapy. Blood 87:4831, 1996. of Francisella tularensis. Infection 14:51, 1986.
126. Sloand EM, Scheinberg P, Maciejewski J, et al: Brief communication: 152. Abdool Gaffar MS, Seedat YK, Coovadia YM, et al: The white cell
Successful treatment of pure red-cell aplasia with an anti-interleukin-2 count in typhoid fever. Trop Geogr Med 44:23, 1992.
receptor antibody (daclizumab). Ann Intern Med 144:181, 2006. 153. Rose HM: The clinical manifestations and laboratory diagnosis of
127. Abkowitz JL, Powell JS, Nakamura JM, et al: Pure red cell aplasia: rickettsialpox. Ann Intern Med 31:871, illust, 1949.
Response to therapy with anti-thymocyte globulin. Am J Hematol 154. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al: Human
23:363, 1986. granulocytic ehrlichiosis: A case series from a medical center in New
128. Arakawa Y, Matsui A, Sasaki N, et al: Agranulocytosis and throm- York State. Ann Intern Med 125:904, 1996.
bocytopenic purpura following measles infection in a living-related 155. Bakken JS, Krueth J, Wilson-Nordskog C, et al: Clinical and labora-
orthotopic liver transplantation recipient. Acta Paediatr Jpn 39:226, tory characteristics of human granulocytic ehrlichiosis. JAMA 275:199,
1997. 1996.